O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 35,141 followers.

Researchers at the Chang Gung Memorial Hospital determined AcGD2 expression in patient-derived xenografts of #BreastCancer by flow cytometric analyses using mAb8D6. #OpenAccess in @FrontImmunol 📍 https://t.co/e13OlhjQpC https://t.co/JezSkoy4hJ

RT @FrontImmunol: New Research: O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells: Synopsis A sugar-lipid molecule called…

RT @FrontImmunol: New Research: O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells: Synopsis A sugar-lipid molecule called…

RT @FrontImmunol: New Research: O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells: Synopsis A sugar-lipid molecule called…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.